Report Library
All Reports
2016 Biomedtracker Post-EASL Hepatitis C Survey
May 16, 2016
We performed a 9-question survey of 29 EU and 31 US hepatologists and gastroenterologists after the European Association of the Study of
the Liver (EASL) International Liver Conference (ILC) from April 13-18, 2016 in Barcelona to gauge current and projected prescribing practices
for hepatitis C virus (HCV) infection.
BioMedTracker will be offering KOL Reports and Physician Pulse Surveys through 2016 for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email BioMedTracker or call BioMedTracker Client Services at (858) 200-2357.
To view the full Post-EASL Hepatitis C Survey, click the link at the top of the page.
If you are a KOL Insight Subscriber, please access this report here, in our KOL Insight portal (Subscribers only).
For our disclosures, please read the BioMedTracker Research Standards.
BioMedTracker will be offering KOL Reports and Physician Pulse Surveys through 2016 for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email BioMedTracker or call BioMedTracker Client Services at (858) 200-2357.
To view the full Post-EASL Hepatitis C Survey, click the link at the top of the page.
If you are a KOL Insight Subscriber, please access this report here, in our KOL Insight portal (Subscribers only).
For our disclosures, please read the BioMedTracker Research Standards.
| Indications Covered: | Hepatitis C (HCV) (Antiviral) |
Additional Resources: